Back to News
Market Impact: 0.42

TD Bank Q2 Earnings: Still A Buy, For Now

Corporate EarningsCorporate Guidance & OutlookBanking & LiquidityCompany FundamentalsCapital Returns (Dividends / Buybacks)Legal & Litigation

Toronto-Dominion Bank delivered a strong Q2, beating revenue and EPS estimates while posting record earnings, high ROE, and robust profitability metrics. Management guided to mid-single-digit expense growth, $500M of AML remediation costs in 2026, and $2.9B of U.S. net income, while also planning to complete a $7B buyback. AML fines are a headwind, but the overall results and capital return outlook remain constructive.

Analysis

The earnings beat matters less as a one-quarter event and more as evidence that TD can still compound through the regulatory overhang. The market should treat the AML remediation line as a deferred P&L drag rather than a balance-sheet threat; that makes the key question not solvency, but how much of the future earnings trajectory is already being capitalized into the multiple. In that sense, the stock’s upside is increasingly driven by buyback math and capital flexibility, not by incremental revenue growth.

Second-order, the cleanest beneficiary is TD itself versus other large banks still facing more open-ended compliance uncertainty. If management really delivers on U.S. earnings stabilization while absorbing remediation costs, the market may start to award TD a rerating toward “resolved-risk” peers, especially if buybacks become visible on a quarterly basis. The loser is any peer with similar legacy issues but weaker profitability, because investors will now compare remediation burden against the ability to offset it with ROE and repurchases.

The main risk is timing mismatch: the next several quarters likely look fine, but the 2026 AML spend creates a visible earnings headwind just as the current optimism peaks. That makes the stock vulnerable to a “good news is priced” setup if macro credit trends soften or if regulators extend the compliance overhang beyond the current estimate. A second risk is that buybacks become a source of disappointment if capital is prioritized for regulatory conservatism rather than execution.

Consensus may be underestimating how much the buyback can cushion the remediation drag, but may also be overestimating the durability of the rerating. For a bank, a 7B repurchase authorization is not just capital return; it is a signal that management is confident enough in normalized earnings power to shrink the float aggressively. If that signal is credible, the trade is more about owning the equity through the repurchase cycle than chasing the immediate post-earnings pop.